Harbor Asset Planning, Inc.
Source: SEC Form 13F · as of Mar 2026Harbor Asset Planning, Inc. holds 17 biotech & pharma companies tracked by BioSniper, totaling $876K in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$876K
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 928 | $227K |
| LLYELI LILLY & Co | 200 | $184K |
| ELVElevance Health Inc. | 276 | $81K |
| ABBVAbbVie Inc. | 313 | $68K |
| NVSNovartis AG | 441 | $67K |
| CAHCardinal Health Inc. | 294 | $62K |
| SUNSUNSET ISLAND GROUP | 762 | $50K |
| GILDGILEAD SCIENCES, INC. | 247 | $34K |
| MRKMerck & Co., Inc. | 285 | $34K |
| PFEPFIZER INC | 850 | $24K |
| ZBHZimmer Biomet Holdings Inc. | 226 | $20K |
| AMGNAMGEN INC | 25 | $9K |
| DGXQuest Diagnostics Incorporated | 32 | $6K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 235 | $4K |
| SNYSanofi | 86 | $4K |
| VTRSViatris Inc | 47 | $633 |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 1 | $50 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.